Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The "Shared Mobility in Rural Areas in Europe, 2024-2030" report has been added to ResearchAndMarkets.com's offering.This study delves into the emerging...
-
Houston, TX, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The US Food and Drug Administration (FDA) has granted EndoQuest Robotics, Inc., a privately-held pioneer in the development of flexible endoluminal...
-
San Francisco, Dec. 10, 2024 (GLOBE NEWSWIRE) -- While companies building consumer apps and prosumer tools invest heavily in personalizing user experiences through product usage data, teams still...
-
Dublin, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease (GvHD) Treatment Market Report 2024" report has been added to ResearchAndMarkets.com's offering. This GvHD treatment...
-
Origami Solar Expands Steel Solar Module Frame Manufacturing with Unimacts in Houston, Texas
-
SANTA CLARA, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) today announced the expansion of the AMD Versal™ adaptive system-on-chip (SoC) portfolio with the introduction of the Versal...
-
Reduction in distant recurrence consistently deepened beyond 3-year Kisqali treatment duration in patients with node-positive (N+) and high-risk node-negative (N0) disease, as well as between...
-
Press Release – No. 12 / 2024 Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesity Zealand Pharma announces that the...
-
Based on more than six months of additional monitoring, data show continued improvement in overall survival (OS) in intent-to-treat (ITT) population of women newly diagnosed with advanced ovarian...
-
Net Sales Decline (3.9)%; Comparable Sales of (4.9)% GAAP Diluted EPS of $0.92, or $0.98 Adjusted Diluted EPS1 Year-to-Date GAAP Operating Cash Flow +29%; Year-to-Date Adjusted Free Cash Flow1...